![Richard Bagley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Bagley
President chez Samus Therapeutics, Inc.
Postes actifs de Richard Bagley
Sociétés | Poste | Début | Fin |
---|---|---|---|
Samus Therapeutics, Inc.
![]() Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA. | President | 01/11/2016 | - |
Historique de carrière de Richard Bagley
Anciens postes connus de Richard Bagley
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALAUNOS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 23/06/2011 | 16/07/2012 |
Directeur des opérations | 01/09/2005 | 16/07/2012 | |
Directeur Financier/CFO | 01/09/2005 | 09/05/2012 | |
President | 01/09/2005 | 16/07/2012 | |
Treasurer | 01/09/2005 | 09/07/2012 | |
ZIOPHARM, Inc. | Directeur des opérations | 01/07/2004 | 01/09/2005 |
President | 01/07/2004 | 01/09/2005 | |
TWIN BUTTE ENERGY LTD. | President | 01/01/1998 | 01/05/2003 |
ProScript, Inc.
![]() ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Président | 01/01/1994 | 01/01/1998 |
President | 01/01/1994 | 01/01/1998 | |
ImmuLogic Pharmaceutical Corp.
![]() ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | President | 01/01/1990 | 01/01/1994 |
E. R. Squibb & Sons LLC | President | 01/01/1988 | 01/01/1989 |
Smithkline & French Laboratories US, Inc. | Corporate Officer/Principal | 01/01/1968 | 01/01/1985 |
Formation de Richard Bagley
Harvard Graduate School of Education | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Canada | 2 |
Opérationnelle
President | 7 |
Chief Operating Officer | 2 |
Director/Board Member | 1 |
Sectorielle
Health Technology | 6 |
Energy Minerals | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ALAUNOS THERAPEUTICS, INC. | Health Technology |
TWIN BUTTE ENERGY LTD. | Energy Minerals |
Entreprise privées | 6 |
---|---|
ImmuLogic Pharmaceutical Corp.
![]() ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. The company focuses on the research and clinical development of products to treat allergies, autoimmune diseases, and vaccines for the management of drugs of abuse. It was founded on March 26, 1987 and is headquartered in Woburn, MN. | Health Technology |
ProScript, Inc.
![]() ProScript, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million. | Health Technology |
ZIOPHARM, Inc. | Health Technology |
Smithkline & French Laboratories US, Inc. | |
E. R. Squibb & Sons LLC | |
Samus Therapeutics, Inc.
![]() Samus Therapeutics, Inc. BiotechnologyHealth Technology Samus Therapeutics, Inc. operates as an biopharmaceutical company. It develops novel therapeutics targeting the epichaperome to enhance degradation of aberrant proteins which drive the pathology of diseases such as neurodegenerative and cancer. The company is headquartered in Topsfield, MA. | Health Technology |
- Bourse
- Insiders
- Richard Bagley
- Expérience